Ultragenyx Pharmaceutical

RARE57

$40.85arrow_drop_down0.46%-$0.18

RARE57

$40.85

arrow_drop_down0.46%-$0.18

Trendlines, Support and Resistance

lock

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Technical Indicators

Name	Value	Action	infoPnL (10y)
auto_graphRSI	65.66	Neutral	22.7%
auto_graphMACD	21.67	Neutral	205.0%
auto_graphCCI	93.64	Neutral	59.5%
auto_graphADX	32.44	Neutral	-
auto_graphATR	20.20	Buy	-
auto_graphWILLR	-18.86	Sell	156.7%
auto_graphROC	39.15	Neutral	201.9%
auto_graphSTOCHRSI	0.00	Buy	-99.2%

Indicator Ratings

Hold

Buy	2	-75.00%
Hold	5	-37.50%
Sell	1	-87.50%

•Ratings from: January•

•Total: 8

info

Balanced or Uncertain

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Ultragenyx Pharmaceutical (RARE) Technical Analysis

Ultragenyx Pharmaceutical Inc, also known as RARE, is a biopharmaceutical company that focuses on the development and commercialization of novel therapeutics for rare diseases. As a company in the healthcare sector, the technical analysis of RARE's stock is an important tool for investors to assess the potential price movements and trends of the stock. Technical analysis uses various indicators to analyze historical price data and identify patterns and trends that can provide insights into future price movements.

One commonly used technical indicator is the relative strength index (RSI). The RSI is a momentum oscillator that measures the speed and change of price movements. It oscillates between 0 and 100, with readings above 70 indicating overbought conditions and readings below 30 indicating oversold conditions. By analyzing the RSI of RARE stock, investors can assess whether the stock is currently overbought or oversold and make informed trading decisions based on this information.

add Ultragenyx Pharmaceutical to watchlist

Keep an eye on Ultragenyx Pharmaceutical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What are the technical signals for Ultragenyx Pharmaceutical (RARE) stock based on the last 30 days?

The technical analysis for Ultragenyx Pharmaceutical (RARE), using 8 key indicators (RSI, MACD, CCI, ADX, ATR, WILLR, ROC, STOCHRSI) over the last 30 days, reveals: 2 technical buy signals, including ATR and STOCHRSI. 1 technical sell signals, identified by ROC. 5 technical hold signals, associated with RSI, MACD, CCI, ADX, and WILLR. This analysis was last updated 2025 Jan 16.